Back to funds
View filing
Rosalind Advisors, Inc.
Updated 6 days agoManaged by Rosalind Advisors, Inc. • Latest filing Q3 2026
Portfolio value
$311.9M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
99.2%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 4 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $284.5M |
| Q1 2026 | $248.9M |
| Q2 2026 | $269.2M |
| Q3 2026 | $311.9M |
Top holdings
46 positions as of Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | $52.7M | 3.30M | 16.90% | — | |
| 2 | $34.1M | 4.24M | 10.94% | — | |
| 3 | $34M | 3.19M | 10.89% | — | |
| 4 | $24.7M | 2.58M | 7.92% | — | |
| 5 | $17.1M | 1.39M | 5.47% | — | |
| 6 | $16.4M | 3.18M | 5.26% | — | |
| 7 | $13.2M | 1.00M | 4.25% | — | |
| 8 | $11.6M | 609.2K | 3.73% | — | |
| 9 | $10.3M | 749.1K | 3.31% | — | |
| 10 | ? N/A X4 PHARMACEUTICALS INC | $9.3M | 3.21M | 2.99% | — |
| 11 | $9.3M | 2.00M | 2.97% | — | |
| 12 | $8.5M | 149.4K | 2.73% | — | |
| 13 | $7.3M | 2.40M | 2.35% | — | |
| 14 | ? N/A MYOMO INC | $6.1M | 3.92M | 1.96% | — |
| 15 | $6M | 721.5K | 1.93% | — | |
| 16 | $5.8M | 2.20M | 1.86% | — | |
| 17 | $4.8M | 2.00M | 1.55% | — | |
| 18 | $4.8M | 828.1K | 1.54% | — | |
| 19 | ? N/A TALPHERA INC | $4.8M | 4.13M | 1.54% | — |
| 20 | $4M | 548.1K | 1.30% | — |